Shilpa Medicare Ltd. has opened its qualified institutional placement of equity shares on Monday and set the issue price at Rs 477.33 apiece.
The issue price indicates a 10% discount to Monday's closing price. It will close on Tuesday, according to the term sheet reviewed by NDTV Profit.
The QIP will result in equity dilution of 11.24% after the issue.
The board had approved the fundraising plan of up to Rs 500 crore in February, which received the shareholders' nod last month.
Shilpa Medicare is a Karnataka-based pharmaceutical company engaged in research and development, manufacturing and sale of oncology and non-oncology APIs (active pharmaceutical ingredient), finished formulations, biologicals, ODF, derma, peptides and polymers, among others.
Shares of the company closed 2.12% higher, ahead of the announcement, as compared with a 0.67% advance in the benchmark BSE Sensex.
RECOMMENDED FOR YOU
.jpg?rect=0%2C0%2C3500%2C1969&w=75)
Navin Fluorine Opens QIP Worth Rs 750 Crore, Fixes Floor Price


CG Power Launches Rs 3,000 Crore QIP, Announces Floor Price


Kaynes Technology Share Price Rises After Launch Of QIP Issue


Sudarshan Pharma Approves To Raise Rs 1,500 Crore Via Equity Issue
